Research Grade Anti-Human IL6/IFNb2 Antibody (MEDI 5117)

Anti-Human IL6/IFNb2 Antibody (MEDI 5117) ( HY328196 ) is a research-grade recombinant antibody targeting Hybridoma growth factor . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns.

Спецификация

Species reactivity	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Form	Liquid
Storage	-20℃
Product category‌	Biosimilar
Target	Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor
Accession	P05231
Host species	Human

Информация для заказа

Область использования: Антитела Puda	Производство:	Puda Scientific
	Метод:	Иммуногистохимия
	Объем:	1mg
	Кат. номер:	PD-A26-662-100
Цена (с НДС 22%):	по запросу	В корзину
Наименование: Research Grade Anti-Human IL6/IFNb2 Antibody (MEDI 5117). Примечание: